HAEMONETICS CORP — Director's Dealing 2010

Oct 29, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2010-10-27

Reporting Person: CONCANNON BRIAN (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-10-27	Common Stock	A	13638.0000	$0.0100	Acquired	39586.0000	Direct
2010-10-28	Common Stock	D	114.0000	$55.1900	Disposed	39472.0000	Direct
2010-10-28	Common Stock	D	398.0000	$55.1900	Disposed	39074.0000	Direct
2010-10-28	Common Stock	D	142.0000	$55.1900	Disposed	38932.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-10-27	Non-Qualified Stock Option (right to buy)	$54.9900	A	118375.0000	Acquired	2017-10-27	Common Stock (118375)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-Qualified Stock Option (right to buy)	$22.6350	2013-09-15	Common Stock (100000)	100000.0000	Direct
Non-Qualified Stock Option (right to buy)	$26.1050	2014-05-05	Common Stock (15000)	15000.0000	Direct
Non-Qualified Stock Option (right to buy)	$41.1500	2012-07-27	Common Stock (19000)	19000.0000	Direct
Non-Qualified Stock Option (right to buy)	$51.0700	2014-10-24	Common Stock (22890)	22890.0000	Direct
Non-Qualified Stock Option (right to buy)	$52.7600	2013-05-05	Common Stock (16644)	16644.0000	Direct
Non-Qualified Stock Option (right to buy)	$52.9400	2016-10-27	Common Stock (79675)	79675.0000	Direct
Non-Qualified Stock Option (right to buy)	$54.5500	2015-10-22	Common Stock (28588)	28588.0000	Direct
Non-Qualified Stock Option (right to buy)	$55.3700	2016-04-02	Common Stock (32845)	32845.0000	Direct

Footnotes

F1: Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.

F2: Pursuant to a 10b5-1 Plan to cover tax liability for released shares.

F3: Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.